Searching in DEA · Search everything
1 change Consultation, last 7 days
DEA Notice: Patheon API Services Controlled Substance Application
The DEA has published a notice regarding an application from Patheon API Services Inc. to be registered as a bulk manufacturer of controlled substances, including Dimethyltryptamine, Psilocybin, Psilocyn, Amphetamine, and Methadone. Interested parties can submit comments or requests for a hearing by May 12, 2026.
Priority review
Consultation
Pharmaceuticals
Get alerts for ""
We'll email you when new changes match this search.
Free. Unsubscribe anytime.